FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer

Figure 4

The relationship between FASN expression and patient prognosis. (a) Kaplan–Meier analysis of BCR-free survival in patients’ data retrieved from TCGA (, ), (b) Correlation between FASN expression and BCR-free survival in GEO dataset (, ). (c) Disease-free survival in TMA patients (, ). The log-rank test shows that PCa patients with high FASN expression have shorter disease-free survival time.

(a)

(b)

(c)